Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chonlatis Srichumpuang

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Orphanet Journal of Rare Diseases|March 27, 2024
Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxisChonlatis Srichumpuang, Arunothai Rakmanotham, Chatphatai Moonla, et al.
BMJ Case Reports|May 2, 2025
Compound heterozygous congenital protein C deficiency: a challenging management with recurrent purpura fulminans treated with protein C concentrationsChonlatis Srichumpuang, Phawin Kor-Anantakul, Leonardo R Brandao, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 31, 2024
Low-Dose Emicizumab Versus Low-/Intermediate-Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding PhenotypeNuchanun Kessakorn, Itsaraet Gosriwatana, Nuttarak Sasipong, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 28, 2022
Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic DiseasesHansamon Poparn, Chonlatis Srichumpuang, Darintr Sosothikul, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Orphanet Journal of Rare Diseases|March 27, 2024
Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxisChonlatis Srichumpuang, Arunothai Rakmanotham, Chatphatai Moonla, et al.
BMJ Case Reports|May 2, 2025
Compound heterozygous congenital protein C deficiency: a challenging management with recurrent purpura fulminans treated with protein C concentrationsChonlatis Srichumpuang, Phawin Kor-Anantakul, Leonardo R Brandao, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 31, 2024
Low-Dose Emicizumab Versus Low-/Intermediate-Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding PhenotypeNuchanun Kessakorn, Itsaraet Gosriwatana, Nuttarak Sasipong, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 28, 2022
Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic DiseasesHansamon Poparn, Chonlatis Srichumpuang, Darintr Sosothikul, et al.
Pageof 1